Jarislowsky, Fraser LTD Abb Vie Inc. Transaction History

Jarislowsky, Fraser LTD

  • $16.1 Billion
  • Q3 2024

A detailed history of Jarislowsky, Fraser LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Jarislowsky, Fraser LTD holds 99,358 shares of ABBV stock, worth $18.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
99,358
Previous 99,533 0.18%
Holding current value
$18.2 Million
Previous $17.1 Million 14.94%
% of portfolio
0.12%
Previous 0.11%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$163.84 - $199.33 $28,672 - $34,882
-175 Reduced 0.18%
99,358 $19.6 Million
Q2 2024

Aug 12, 2024
SELL
$154.79 - $180.76 $4.98 Million - $5.81 Million
-32,145 Reduced 24.41%
99,533 $17.1 Million
Q1 2024

Sep 30, 2024
SELL
$159.82 - $182.1 $1.91 Million - $2.18 Million
-11,954 Reduced 8.32%
131,678 $24 Million
Q1 2024

May 13, 2024
SELL
$159.82 - $182.1 $1.91 Million - $2.18 Million
-11,954 Reduced 8.32%
131,678 $24 Million
Q4 2023

Sep 30, 2024
BUY
$137.6 - $154.97 $6.07 Million - $6.83 Million
44,099 Added 44.31%
143,632 $22.3 Million
Q4 2023

Feb 12, 2024
BUY
$137.6 - $154.97 $75,267 - $84,768
547 Added 0.38%
143,632 $22.3 Million
Q3 2023

Sep 30, 2024
BUY
$133.59 - $154.65 $5.82 Million - $6.74 Million
43,552 Added 43.76%
143,085 $21.3 Million
Q3 2023

Nov 06, 2023
SELL
$133.59 - $154.65 $44,485 - $51,498
-333 Reduced 0.23%
143,085 $21.3 Million
Q2 2023

Sep 27, 2024
SELL
$132.51 - $164.9 $393,157 - $489,258
-2,967 Reduced 2.03%
143,418 $19.3 Million
Q2 2023

Jul 19, 2023
SELL
$132.51 - $164.9 $393,157 - $489,258
-2,967 Reduced 2.03%
143,418 $19.3 Million
Q1 2023

Sep 27, 2024
BUY
$144.61 - $166.54 $6.78 Million - $7.8 Million
46,852 Added 47.07%
146,385 $23.3 Million
Q1 2023

May 11, 2023
SELL
$144.61 - $166.54 $621,967 - $716,288
-4,301 Reduced 2.85%
146,385 $23.3 Million
Q4 2022

Sep 27, 2024
BUY
$138.31 - $165.87 $7.07 Million - $8.48 Million
51,153 Added 51.39%
150,686 $24.4 Million
Q4 2022

Feb 10, 2023
SELL
$138.31 - $165.87 $27,662 - $33,174
-200 Reduced 0.13%
150,686 $24.4 Million
Q3 2022

Nov 07, 2022
SELL
$134.21 - $153.93 $93,947 - $107,751
-700 Reduced 0.46%
150,886 $20.3 Million
Q2 2022

Jul 27, 2022
SELL
$137.62 - $174.96 $92,893 - $118,098
-675 Reduced 0.44%
151,586 $23.2 Million
Q1 2022

May 12, 2022
SELL
$131.98 - $163.75 $372,843 - $462,593
-2,825 Reduced 1.82%
152,261 $24.7 Million
Q4 2021

Feb 10, 2022
SELL
$107.43 - $135.93 $2.82 Million - $3.57 Million
-26,290 Reduced 14.49%
155,086 $21 Million
Q3 2021

Nov 12, 2021
SELL
$106.4 - $120.78 $303,240 - $344,223
-2,850 Reduced 1.55%
181,376 $19.6 Million
Q2 2021

Aug 09, 2021
SELL
$105.21 - $117.21 $578,128 - $644,068
-5,495 Reduced 2.9%
184,226 $20.8 Million
Q1 2021

May 13, 2021
SELL
$102.3 - $112.62 $117,645 - $129,513
-1,150 Reduced 0.6%
189,721 $20.5 Million
Q4 2020

Feb 11, 2021
BUY
$80.49 - $108.67 $4,024 - $5,433
50 Added 0.03%
190,871 $20.5 Million
Q3 2020

Nov 03, 2020
SELL
$85.91 - $100.83 $204,036 - $239,471
-2,375 Reduced 1.23%
190,821 $16.7 Million
Q2 2020

Aug 12, 2020
SELL
$73.37 - $98.18 $581,457 - $778,076
-7,925 Reduced 3.94%
193,196 $19 Million
Q1 2020

May 13, 2020
SELL
$64.5 - $97.79 $1.28 Million - $1.94 Million
-19,825 Reduced 8.97%
201,121 $15.3 Million
Q4 2019

Feb 13, 2020
SELL
$72.13 - $90.25 $240,409 - $300,803
-3,333 Reduced 1.49%
220,946 $19.6 Million
Q3 2019

Nov 13, 2019
SELL
$62.98 - $75.72 $503,210 - $605,002
-7,990 Reduced 3.44%
224,279 $17 Million
Q2 2019

Aug 13, 2019
SELL
$65.7 - $83.98 $419,625 - $536,380
-6,387 Reduced 2.68%
232,269 $16.9 Million
Q1 2019

May 15, 2019
SELL
$77.14 - $90.79 $509,818 - $600,031
-6,609 Reduced 2.69%
238,656 $19.2 Million
Q4 2018

Feb 01, 2019
SELL
$77.85 - $96.01 $122,613 - $151,215
-1,575 Reduced 0.64%
245,265 $22.6 Million
Q3 2018

Nov 14, 2018
SELL
$88.91 - $98.84 $311,985 - $346,829
-3,509 Reduced 1.4%
246,840 $19.2 Million
Q2 2018

Aug 10, 2018
SELL
$89.78 - $106.23 $489,570 - $579,272
-5,453 Reduced 2.13%
250,349 $23.2 Million
Q1 2018

May 14, 2018
SELL
$92.01 - $123.21 $361,139 - $483,599
-3,925 Reduced 1.51%
255,802 $0
Q4 2017

Feb 13, 2018
BUY
$89.56 - $98.21 $25,345 - $27,793
283 Added 0.11%
259,727 $0
Q3 2017

Nov 06, 2017
BUY
$69.85 - $89.22 $18.1 Million - $23.1 Million
259,444
259,444 $23.1 Million

Others Institutions Holding ABBV

# of Institutions
3,849
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jarislowsky, Fraser LTD Portfolio

Follow Jarislowsky, Fraser LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email